trotabresib (BMS-986378) / BMS  >>  Phase 1
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trotabresib (BMS-986378) / BMS
NCT04047303: CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma

Completed
1
20
Europe, US
CC-90010
Celgene
Astrocytoma, Glioblastoma
06/24
06/24
NCT04324840: A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma

Active, not recruiting
1
194
Europe, US
CC-90010, Temozolomide, Radiotherapy
Celgene
Glioblastoma
05/24
05/26
NCT03220347: A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects With Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin's Lymphomas

Active, not recruiting
1
139
Europe, Japan
CC-90010
Celgene
Lymphoma, Non-Hodgkin, Neoplasms
06/24
06/26
NCT05678283: A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors

Withdrawn
1
8
Europe
[14C]CC-90010, CC-90010, BMS-986378
Bristol-Myers Squibb
Advanced Solid Tumors
04/24
04/24

Download Options